Frank Ruffo

ACRS

Frank Ruffo serves as Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$3.09M

Net Position

Net Seller

$3.09M

Companies Traded

ACRS

Active Period

Mar 2021 – Mar 2022

5 total trades

Most Recent

Sell ACRS

Mar 10, 2022 · $199.3K

Frank Ruffo's Insider Trading at Aclaris Therapeutics, Inc. (ACRS)

Buys

0 · $0.00

Sells

5 · $3.09M

Total Shares Bought

Total Shares Sold

126,764

ACRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 10, 2022↗	Sell	12,823	$15.55	$199.3K
Feb 9, 2022↗	Sell	1,388	$12.66	$17.6K
Jun 1, 2021↗	Sell	15,037	$21.64	$325.4K
Apr 22, 2021↗	Sell	87,339	$26.45	$2.31M
Mar 1, 2021↗	Sell	10,177	$23.83	$242.6K

Related Insiders

Kevin Balthaser

Chief Financial Officer

ACRSSell · Feb 3, 2026

James Loerop

Chief Business Officer

ACRSSell · Feb 3, 2026

Neal Walker

CEO

ACRSSell · Feb 3, 2026

Explore More Insider Trading Data

ACRS Insider Trading Activity

View all insider trades at Aclaris Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity